We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMODX
RNS Number : 9840J
Omega Diagnostics Group PLC
22 August 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega", the "Company" or the "Group")
Directorate Change
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as a Director and leaving the Company with immediate effect.
Chris has been instrumental in selling the Alva site and subsequent sale of the CD4 Business along with a restructuring of Omega, based in Ely, Cambridgeshire . The restructuring and disposals were key in refocusing the Company on food intolerance testing and ensuring it has sufficient resources to drive Omega forward. Chris is based in Scotland and his stepping down is in line with the Company strategy to focus more of its resources in and around the Company's headquarters in Ely, Cambridge.
As per the recent results, the Company remains very well-funded with GBP5.1m of cash at 31 March 2023. This is more than sufficient to build on the platform Omega has to drive a profitable and sustainable Company.
Omega intends to change its name to Cambridge Nutritional Sciences at the upcoming Annual General Meeting and intends to appoint an interim CFO shortly.
Simon Douglas, Chairman of Omega, said: "We thank Chris for all his efforts and fully appreciate how instrumental he was in the refocusing and restructuring of the Company. We wish him all the best for the future."
Contacts:
Omega Diagnostics Group PLC www.omegadx.com Jag Grewal, Chief Executive Officer via Walbrook PR finnCap Ltd Tel: 020 7220 0500 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) Nigel Birks/Harriet Ward (ECM) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Applegarth Mob: 07584 391 303 Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 85 countries and is now focused on the health and nutrition sector. www.omegadx.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAPPUPWRUPWGQG
(END) Dow Jones Newswires
August 22, 2023 02:00 ET (06:00 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions